Sunrest Lifescience

Sunrest Lifescience Pre-Tax Margin

The Pre-Tax Profit Margin of Sunrest Lifescience (SUNREST.NS) as of Nov 3, 2026 is 7.85 %. In the previous year, Pre-Tax Profit Margin was 2.01 % — a change of 290.53% (higher).

Pre-Tax Margin

7.85 %

YoY

290.53%

Last updated:

Pre-Tax Profit Margin of Sunrest Lifescience is 2025 7.85 % . Pre-Tax Profit Margin of Sunrest Lifescience was 2024 2.01 % . It decreases by 290.53% higher compared to the previous year.

The Sunrest Lifescience Pre-Tax Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Pre-Tax Margin
Date
Pre-Tax Margin
Jan 1, 2021
1.30 INR
Jan 1, 2022
3.90 INR
Jan 1, 2023
11.12 INR
Jan 1, 2024
2.01 INR
Jan 1, 2025
7.85 INR
The Sunrest Lifescience Pre-Tax Margin history
YEARPre-Tax MarginYoY
7.85 %+290.53%
2.01 %-81.92%
11.12 %+184.78%
3.90 %+200.85%
1.30 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sunrest Lifescience Stock analysis

What does Sunrest Lifescience do? Sunrest Lifescience Ltd markets OTC generic pharmaceutical products manufactured by third party manufacturers. The company sells capsules, tablets, syrup, ointment, gel, mouth wash, solution, suspension, dry powders, and toothpaste. Its product portfolio includes Anti-Bacterial, Anti Diarrheal, Antifungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory drugs. The company operates in Maharashtra, Gujarat, Madhya Pradesh, Orissa, and Rajasthan, selling to stockists who distribute products to chemist shops, dispensaries, and hospitals. Sunrest Lifescience Ltd targets domestic markets through third party manufacturers for OTC generic products. The firm's sales channels include stockists who supply chemist shops, dispensaries, and hospitals across multiple Indian states. The company's product range serves various health segments from anti-bacterial treatments to multivitamins and dental care. The company's revenue comes from the sale of OTC generic pharmaceutical products to stockists, who then distribute them to end consumers via chemist shops, dispensaries, and hospitals. Sunrest Lifescience Ltd focuses on domestic market distribution without direct retail presence, leveraging third party manufacturers for product supply. Sunrest Lifescience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunrest Lifescience stock

Pre-Tax Profit Margin of Sunrest Lifescience is 7.85 % in 2025.

Pre-Tax Profit Margin of Sunrest Lifescience changed from 2.01 % to 7.85 %, representing a 290.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Pre-Tax Profit Margin Sunrest Lifescience since 2006 – with annual values, charts, and detailed analysis.

Pre-tax margin measures the percentage of revenue remaining after all expenses except income taxes. It isolates operational and financial performance from tax effects.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Pre-Tax Profit Margin's Sunrest Lifescience with sector peers and the industry average to assess whether it is attractive.

To evaluate Pre-Tax Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Pre-Tax Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Sunrest Lifescience

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Sunrest Lifescience